佐登-KY

-0.10 (-0.39%)最後更新 2026-09-11

台灣 · 上市 · 生技醫療業

25.8512成交張數–本益比0.95股價淨值比1.93%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	72	16	77.7%	0.65	26.25	-5.3%	-1.2%	0.9	0.8
2026Q1	67	16	76.1%	0.48	26.24	-4.9%	-1.2%	1.0	0.8
2025Q4	68	16	75.9%	0.48	26.52	-5.5%	-1.3%	1.6	1.5
2025Q3	68	16	77.1%	0.45	25.23	-8.3%	-1.9%	1.5	1.3
2025Q2	68	16	77.1%	0.54	25.04	-11.9%	-2.8%	0.7	0.5
2025Q1	73	17	76.0%	0.58	28.21	-12.3%	-3.0%	1.2	1.0
2024Q4	74	18	76.0%	0.58	28.58	-15.2%	-3.8%	1.5	1.2
2024Q3	83	19	77.5%	0.73	30.73	-13.2%	-3.3%	0.6	0.3
2024Q2	77	19	75.6%	0.53	30.98	-10.5%	-2.7%	1.1	0.7
2024Q1	78	19	75.2%	0.54	31.90	-4.8%	-1.2%	1.0	0.4
2023Q4	79	21	73.6%	0.53	34.02	-0.0%	0.0%	1.7	1.1
2023Q3	80	22	73.0%	0.54	35.10	-0.3%	-0.1%	0.8	0.1
2023Q2	79	21	72.8%	0.53	35.06	1.0%	0.3%	2.6	1.2
2023Q1	81	21	73.7%	0.52	34.85	0.5%	0.1%	2.1	1.1
2022Q4	80	22	73.2%	0.50	35.49	0.6%	0.2%	2.9	1.2
2022Q3	80	22	72.7%	0.71	35.80	5.7%	1.6%	1.2	-0.9
2022Q2	79	22	72.4%	0.74	35.75	8.1%	2.3%	1.4	-0.7
2022Q1	80	22	72.9%	0.78	35.52	10.7%	3.0%	1.9	0.3
2021Q4	84	23	73.0%	0.88	37.50	13.4%	3.8%	2.9	1.4
2021Q3	75	21	71.6%	0.59	35.10	16.6%	4.7%	2.2	0.6
2021Q2	73	21	71.1%	0.57	34.45	19.8%	5.7%	1.9	0.4
2021Q1	72	21	70.3%	0.56	35.07	16.7%	5.1%	2.9	1.3
2020Q4	70	21	70.5%	0.54	34.02	12.6%	3.8%	3.2	1.5
2020Q3	66	19	71.2%	0.50	31.20	15.0%	4.3%	2.9	2.2
2020Q2	63	18	71.8%	0.41	29.25	15.8%	4.4%	2.2	0.9
2020Q1	63	20	68.2%	0.43	32.69	19.5%	5.8%	0.7	-0.8
2019Q4	65	20	68.8%	0.58	33.18	24.2%	7.5%	2.4	1.3
2019Q3	66	19	71.7%	0.58	30.68	25.5%	7.8%	1.2	0.7
2019Q2	67	18	72.5%	0.57	30.13	28.4%	8.2%	2.6	2.2
2019Q1	70	20	71.9%	0.69	32.36	27.1%	8.0%	1.6	1.2
2018Q4	60	19	68.9%	0.78	30.54	31.7%	9.5%	1.5	0.8
2018Q3	51	17	67.0%	0.48	27.46	27.4%	8.5%	1.4	0.9
2018Q2	51	16	69.0%	0.48	26.06	24.0%	7.1%	1.0	0.5
2018Q1	51	16	68.5%	0.47	26.23	15.6%	5.1%	0.5	-0.6
2017Q4	51	15	71.2%	0.47	23.94	12.4%	4.0%	1.6	1.2
2017Q3	49	14	70.9%	0.46	23.17	16.3%	5.5%	1.1	0.8
2017Q2	48	13	72.1%	0.51	21.95	18.3%	5.9%	0.7	0.1
2017Q1	44	15	65.8%	0.48	24.41	17.3%	6.9%	0.9	0.5
2016Q4	40	15	63.5%	0.54	24.06	–	–	0.9	0.2
2016Q3	35	14	60.2%	0.56	22.63	–	–	0.6	0.2